Page 29 - Prophylaxis For Spring News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Prophylaxis for spring. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Prophylaxis For Spring Today - Breaking & Trending Today

Intensive Gout Treatment Meets Urate Goal, Lowers Tophi Burden

The second randomized trial of therapy to intensively lower urate for patients with gout showed benefits in meeting serum urate goal, tophus size, and decreasing ultrasound sign. ....

United States , Boston University , United Kingdom , Tuhina Neogi , British Society For Rheumatology , Boston Medical Center , Tight Control , British Society , Medscape Medical News , Care Management , Clinical Guidelines , Health Education Counseling , Patient Education , Primary Care , Renal Failure , Enal Insufficiency , Idney Insufficiency , Kidney Failure ,

Β cyclodextrin family found to be promising and cost-effective antiviral agents against SARS-CoV-2

Researchers identified β-cyclodextrins (β-CDs) as a safe and cost-effective drug against SARS-CoV-2 with a broad spectrum of activity. ....

Genomics Industry Focus , Coronavirus Disease Covid 19 , Ars Cov 2 , Covid 19 , Evere Acute Respiratory , Evere Acute Respiratory Syndrome ,

From A to Y: Meningococcal Diseases and Vaccination

A vaccination campaign against meningococcal B bacteria has been initiated in the Chambéry and Lyon-East regions of France following an increase in infections with a new variant. ....

Haute Normandie , Saharan Africa , Meningococcal Infection , Meningococcal Disease , Travel Medicine Vaccination , Bloodstream Infections , Travel Medicine , Septic Shock , Oint Inflammation , Purpura Fulminans ,

EHR-based Thromboembolism Risk Tools Boosts Prophylaxis

A clinical decision-support tool designed to identify hospitalized patients in need of VTE prophylaxis cut the rate of thromboembolism at 30 days in the randomized IMPROVE-DD VTE trial. ....

United States , New York , Boston University , Alexc Spyropoulos , Elainem Hylek , Gregory Piazza , American Heart Association , Northwell Health , Agency For Healthcare Research , More Detail , Healthcare Research , Healthcare Technology , Ealth Care Technology , Electronic Medical Record Emr , Electronic Medical Record , Omputerized Medical Records Systems , Anticoagulation Therapy , Atrial Fibrillation , F Atrial Fibrillation , 019 Novel Coronavirus , 019 Ncov , Uhan Coronavirus , Uman Coronavirus Hku1 , Uman Coronavirus Oc4 ,

Monoclonal Antibodies an Option for Oncohematology Patients

Monoclonal antibodies are the best option against SARS-CoV-2 for oncohematology patients, although viral variants may reduce the efficacy of these treatments. ....

United States , United Kingdom , Comunidad Autonoma De Cataluna , Karmele Arribalzaga , Spanish Ministry Of Health , National Institutes Of Health , International Society On Thrombosis , Hemostasis Unit Of The Navarra University Clinic , American Society Of Hematology , European Medicines Agency , Foundation University Hospital , University Clinical Hospital Of Valladolid , Association For The Advancement Of Blood Biotherapies , University Clinical Hospital , Princesa De La Hospital , National Institutes , Spanish Ministry , Infectious Diseases Department , Hospital Clinic , Hemostasis Unit , Navarra University Clinic , New England Journal , International Society , American Society , 019 Novel Coronavirus , 019 Ncov ,